SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 120 filers reported holding SERES THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $483,000 | -8.3% | 20,243 | -20.9% | 0.01% | -12.5% |
| Q1 2021 | $527,000 | +19.0% | 25,585 | +41.5% | 0.01% | +14.3% |
| Q4 2020 | $443,000 | +8.8% | 18,079 | +25.9% | 0.01% | -12.5% |
| Q3 2020 | $407,000 | +601.7% | 14,362 | +17.1% | 0.01% | +700.0% |
| Q2 2020 | $58,000 | – | 12,266 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |